The Arkansas Insurance Department (AID) published a rule this week that gives force to the state’s ground-breaking 2021 law prohibiting drug makers from denying 340B pricing or restricting access to drugs when covered entities contract with pharmacies to dispense 340B drugs to patients.
Rule 123, issued Monday, says a drug maker cannot prohibit a pharmacy from contracting or participating with a 340B covered entity by denying the pharmacy access to the drugs it manufactures. Drug companies are further barred from denying or prohibiting 340B drug pricing for an Arkansas-based community pharmacy that receives drugs purchased under a 340B drug pricing contract-pharmacy arrangement with a covered entity. Rule 123 takes effect no later than Sept. 30, AID officials said.
The Arkansas Insurance Department (AID) published a rule this week that gives force to the state’s ground-breaking 2021 law prohibiting drug makers from denying 340B pricing or restricting access to drugs when covered entities contract with pharmacies to dispense 340B drugs to patients.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
